These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 33002406)

  • 1. Growth arrest or drug target inactivity is not sufficient for persister formation in E. coli.
    Xu Y; Cui P; Zhang Y; Zhang W
    Discov Med; 2020; 29(157):103-112. PubMed ID: 33002406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Travelers' Diarrhea-Associated Enterotoxigenic Escherichia coli gyrA Mutants and Quinolone Antibiotic Affinity: A Molecular Dynamics Simulation and Residue Interaction Network Analysis.
    Mehla K; Ramana J
    OMICS; 2016 Nov; 20(11):635-644. PubMed ID: 27753544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophages and Growth Dynamics Confound Experimental Results with Antibiotic-Tolerant Persister Cells.
    Harms A; Fino C; Sørensen MA; Semsey S; Gerdes K
    mBio; 2017 Dec; 8(6):. PubMed ID: 29233898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas9/sgRNA-mediated targeted gene modification confirms the cause-effect relationship between gyrA mutation and quinolone resistance in Escherichia coli.
    Qiu H; Gong J; Butaye P; Lu G; Huang K; Zhu G; Zhang J; Hathcock T; Cheng D; Wang C
    FEMS Microbiol Lett; 2018 Jul; 365(13):. PubMed ID: 29767711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATP-Dependent Persister Formation in Escherichia coli.
    Shan Y; Brown Gandt A; Rowe SE; Deisinger JP; Conlon BP; Lewis K
    mBio; 2017 Feb; 8(1):. PubMed ID: 28174313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Throughput Screening of a Promoter Library Reveals New Persister Mechanisms in Escherichia Coli.
    Mohiuddin SG; Massahi A; Orman MA
    Microbiol Spectr; 2022 Feb; 10(1):e0225321. PubMed ID: 35196813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli.
    Li Y; Zhang Y
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2092-9. PubMed ID: 17420206
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Mohiuddin SG; Massahi A; Orman MA
    mBio; 2022 Feb; 13(1):e0218721. PubMed ID: 35038905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observation of a new pattern of mutations in
    Dasgupta N; Paul D; Chanda DD; Chetri S; Chakravarty A; Bhattacharjee A
    Indian J Med Microbiol; 2018; 36(1):131-135. PubMed ID: 29735844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stationary phase persister formation in Escherichia coli can be suppressed by piperacillin and PBP3 inhibition.
    Aedo SJ; Orman MA; Brynildsen MP
    BMC Microbiol; 2019 Jun; 19(1):140. PubMed ID: 31234796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific Enrichment and Proteomics Analysis of Escherichia coli Persisters from Rifampin Pretreatment.
    Sulaiman JE; Hao C; Lam H
    J Proteome Res; 2018 Nov; 17(11):3984-3996. PubMed ID: 30336045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Genetic Determinant of Persister Cell Formation in Bacterial Pathogens.
    Cameron DR; Shan Y; Zalis EA; Isabella V; Lewis K
    J Bacteriol; 2018 Sep; 200(17):. PubMed ID: 29941425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reassessing the Role of Type II Toxin-Antitoxin Systems in Formation of Escherichia coli Type II Persister Cells.
    Goormaghtigh F; Fraikin N; Putrinš M; Hallaert T; Hauryliuk V; Garcia-Pino A; Sjödin A; Kasvandik S; Udekwu K; Tenson T; Kaldalu N; Van Melderen L
    mBio; 2018 Jun; 9(3):. PubMed ID: 29895634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mutational landscape of quinolone resistance in Escherichia coli.
    Bhatnagar K; Wong A
    PLoS One; 2019; 14(11):e0224650. PubMed ID: 31689338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Integration Host Factor in Escherichia coli Persister Formation.
    Nicolau SE; Lewis K
    mBio; 2022 Feb; 13(1):e0342021. PubMed ID: 34982597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of oxidative stress in persister tolerance.
    Wu Y; Vulić M; Keren I; Lewis K
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4922-6. PubMed ID: 22777047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stationary-phase genes upregulated by polyamines are responsible for the formation of Escherichia coli persister cells tolerant to netilmicin.
    Tkachenko AG; Kashevarova NM; Tyuleneva EA; Shumkov MS
    FEMS Microbiol Lett; 2017 May; 364(9):. PubMed ID: 28431088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AldB controls persister formation in Escherichia coli depending on environmental stress.
    Kawai Y; Matsumoto S; Ling Y; Okuda S; Tsuneda S
    Microbiol Immunol; 2018 May; 62(5):299-309. PubMed ID: 29577369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical profiling of mutations in quinolone resistance determining region of gyrA gene among UPEC.
    Varughese LR; Rajpoot M; Goyal S; Mehra R; Chhokar V; Beniwal V
    PLoS One; 2018; 13(1):e0190729. PubMed ID: 29300775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (p)ppGpp-Dependent Persisters Increase the Fitness of Escherichia coli Bacteria Deficient in Isoaspartyl Protein Repair.
    VandenBerg KE; Ahn S; Visick JE
    Appl Environ Microbiol; 2016 Sep; 82(17):5444-54. PubMed ID: 27371580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.